Friedrichsdorf (Ts.) / Mannheim / Basel, January 1st 2016: PharmaLex Group announces the opening of an affiliate office in Basel to further strengthen and support the growing local and international customer base in Switzerland. With this foundation PharmaLex reaches another key milestone to drive internationalization aiming for “Global Reach with Local Presence”.
PharmaLex is now able to complete its portfolio with Customer On-Site (COS) support for scientific services, regulatory affairs and pharmacovigilance for Swiss pharmaceutical companies. The new affiliate is led by Michal Bartos, who has 30 years of experience in the pharmaceutical industry with large multinational companies and as an independent management consultant.
“We have seen a very positive development in the entire DACH region and our new office in Switzerland will be of particular strategic importance, as we want to expand our services to the hotspot of the Swiss pharmaceutical industry,” said Dr. Thomas Dobmeyer, Chief Executive Officer of the PharmaLex Group. “The appointment of Michal Bartos, guarantees that PharmaLex in Switzerland is accompanied with extensive experience of local specifics within the international transformation” is pointed out by Dr. Tilo Netzer, Chief Executive Officer of the PharmaLex Group.
PharmaLex combines local expertise with global reach in the area of scientific services, regulatory affairs and pharmacovigilance. We have extensive experience in all therapeutic areas and product groups including advanced therapy medicinal products and biopharmaceuticals, medicinal and borderline products and alternative therapeutic approaches. We have a proven track record of success in outsourcing programs with more than 25,000 successfully completed projects for over 500 clients worldwide.
For further information, please contact:
Ms. Eva Keck
PharmaLex GmbH; Director Business Development Operations
+49 621 18 15 38 0
Harrlachweg 6; 68163 Mannheim